title: Update in the Management of Patients with Preeclampsia.
abstract: Hypertensive disorders of pregnancy complicate approximately 10% of all deliveries in the United States and are a leading cause of maternal and fetal morbidity and mortality. Preeclampsia is defined as hypertension in association with proteinuria, thrombocytopenia, impaired liver function, renal insufficiency, pulmonary edema, or new-onset cerebral or visual disturbances. The greatest risk factor for the development of preeclampsia is a history of preeclampsia. There currently is no effective means for the prevention of preeclampsia. Approximately 39% of patients diagnosed with preeclampsia have hypertension and approximately 20% have proteinuria 3 months postpartum. Preeclampsia increases the risk of patients developing hypertension later in life.
authors.affiliation: Department of Anesthesiology, Emory University, 1354 Clifton Road Northeast, Atlanta, GA 30322, USA.
authors.forename: Nerlyne K
authors.initials: NK
authors.lastname: Dhariwal
authors.affiliation: Department of Anesthesiology, Emory University, 1354 Clifton Road Northeast, Atlanta, GA 30322, USA. Electronic address: glynde@emory.edu.
authors.forename: Grant C
authors.initials: GC
authors.lastname: Lynde
mesh_terms: D000773:Anesthesia, Obstetrical; D005260:Female; D006801:Humans; D018743:Perinatal Care / Q000379:methods*; D011225:Pre-Eclampsia / Q000517:prevention & control / Q000628:therapy*; D011247:Pregnancy; D012307:Risk Factors
keywords: Biomarkers; Hypertension; Magnesium sulfate; Preeclampsia; Renal dysfunction